Environmental risk factors, protective factors, and biomarkers for postpartum depressive symptoms: an umbrella review.
Journal: Neuroscience and biobehavioral reviews
Volume: 140
Issue:
Year of Publication: 2022
Affiliated Institutions:
Yonsei University College of Medicine, Seoul, the Republic of Korea.
Department of Psychiatry, Yonsei University College of Medicine, Seoul, the Republic of Korea.
Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; South London and Maudsley NHS Foundation Trust, London, UK; Faculty of Health, Social Care and Education, Anglia Ruskin University, Chelmsford, UK.
Parc Sanitari Sant Joan de Déu/CIBERSAM, Universitat de Barcelona, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain; ICREA, Pg. Lluis Companys , Barcelona, Spain.
Pain and Rehabilitation Centre, and Department of Health, Medicine and Caring Sciences, Linkoping University, Linkoping, Sweden.
Research and Development Unit, Parc Sanitari Sant Joan de Déu, CIBERSAM, Dr. Antoni Pujadas, , Sant Boi de Llobregat, Barcelona , Spain; Faculty of Medicine, University of Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France.
Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Early Psychosis: Interventions and Clinical-detection (EPIC) lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK; Imaging of Mood, and Anxiety-Related Disorders (IMARD) group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Mental Health Research Networking Center (CIBERSAM), Barcelona, Spain; Centre for Psychiatric Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Department of Psychology, University of Greenwich, London, UK.
The Cambridge Centre for Sport and Exercise Sciences, Anglia Ruskin University, Cambridge, UK.
School of Social Work, University of Southern California, CA , USA.
Department of Cancer Epidemiology and Prevention Research, Alberta Health Services, Calgary, Canada; Departments of Oncology and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Department of Neuroscience, Reproductive Sciences and Dentistry, Federico II University, Naples, Italy.
Department of Preventive Intervention for Psychiatric Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan; Stockholm Center for Health and Social Change (SCOHOST), Södertörn University, Huddinge, Sweden.
Early Psychosis: Interventions and Clinical-detection (EPIC) lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK; Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK; Institute of Psychiatry and Mental Health. Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón School of Medicine, Universidad Complutense, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), CIBERSAM, Madrid, Spain.
Department of Basic Sciences, Medicine Faculty of Tunis, Tunis El Manar University, Rue Djebel Lakdar, Tunis , Tunisia.
Department of Pediatrics, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, the Republic of Korea.
Department of Data Science, Sejong University College of Software Convergence, Seoul, the Republic of Korea.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.
Department of Pediatrics, Yonsei University College of Medicine, Seoul, the Republic of Korea. Electronic address: shinji@yuhs.ac.
Early Psychosis: Interventions and Clinical-detection (EPIC) lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK; Department of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy; OASIS service, South London and Maudsley NHS Foundation Trust, London, UK; National Institute of Health Research Maudsley Biomedical Research Centre, South London and Maudsley NHS Foundation Trust, London, UK.
Abstract summary
We performed an umbrella review on environmental risk/protective factors and biomarkers for postpartum depressive symptoms to establish a hierarchy of evidence. We systematically searched PubMed, Embase, and the Cochrane Database of Systematic Reviews from inception until 12 January 2021. We included systematic reviews providing meta-analyses related to our research objectives. Methodological quality was assessed by AMSTAR 2, and the certainty of evidence was evaluated by GRADE. This review was registered in PROSPERO (CRD42021230784). We identified 30 articles, which included 45 environmental risk/protective factors (154,594 cases, 7,302,273 population) and 9 biomarkers (2018 cases, 16,757 population). The credibility of evidence was convincing (class I) for antenatal anxiety (OR 2.49, 1.91-3.25) and psychological violence (OR 1.93, 1.54-2.42); and highly suggestive (class II) for intimate partner violence experience (OR 2.86, 2.12-3.87), intimate partner violence during pregnancy (RR 2.81, 2.11-3.74), smoking during pregnancy (OR 2.39, 1.78-3.2), history of premenstrual syndrome (OR 2.2, 1.81-2.68), any type of violence experience (OR 2.04, 1.72-2.41), primiparity compared to multiparity (RR 1.76, 1.59-1.96), and unintended pregnancy (OR 1.53, 1.35-1.75).
Authors & Co-authors:
Kim Jae Han JH
Kim Jong Yeob JY
Lee Seul S
Lee San S
Stubbs Brendon B
Koyanagi Ai A
Dragioti Elena E
Jacob Louis L
Carvalho Andre F AF
Radua Joaquim J
Thompson Trevor T
Smith Lee L
Oh Hans H
Yang Lin L
Fornaro Michele M
Stickley Andrew A
de Pablo Gonzalo Salazar GS
Tizaoui Kalthoum K
Yon Dong Keon DK
Lee Seung Won SW
Hwang Jimin J
Il Shin Jae J
Fusar-Poli Paolo P
Study Outcome
Source Link: Visit source